Lanean...
Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic
Comorbidities in rheumatic and musculoskeletal diseases (RMDs) not only increase morbidity and mortality but also confound disease activity, limit drug usage and increase chances of severe infections or drug-associated adverse effects. Most RMDs lead to accelerated atherosclerosis and variable manif...
Gorde:
| Argitaratua izan da: | Rheumatol Int |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer Berlin Heidelberg
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7778868/ https://ncbi.nlm.nih.gov/pubmed/33388969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00296-020-04764-5 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|